ArticlePDF Available

Susceptibility to Cerebral Infarction in the Stroke-Prone Spontaneously Hypertensive Rat Is Inherited as a Dominant Trait Editorial Comment

Authors:

Abstract and Figures

Susceptibility to cerebral infarction was compared in stroke-prone spontaneously hypertensive (SHRSP), normotensive Wistar-Kyoto (WKY) rats, and F1 hybrids derived from a SHRSP/WKY cross. The proximal left middle cerebral artery (MCA) was occluded under anesthesia and infarct volume assessed 24 hours later by magnetic resonance imaging and confirmed 5 days later by quantitative histopathology. Total hemispheric infarct volume was expressed as a percentage of the total brain volume. Infarct volumes measured by MRI in adult SHRSP (19.5 +/- 2.0%) and F1 hybrid rats (19.4 +/- 1.9%) were significantly greater than in WKY (11.1 +/- 2.4; CI [6.07, 10.76]) and (5.93, 10.52), respectively, P<.001). Sensitivity to an ischemic insult was unrelated to blood pressure: although systolic blood pressures differed between young versus adult male SHRSP and between female versus male SHRSP and F1 hybrids, infarct volumes were equal. A close correlation was found between infarct volumes measured by MRI and histology (r=.92, P<.0001). Outcome to MCA occlusion (MCAO) measured with MRI provides a reproducible and nonterminal quantitative phenotypic marker of stroke susceptibility in the SHRSP. This is the first study to employ MCAO with MRI to quantify stroke susceptibility in F1 hybrid rats and indicates a dominant mode of inheritance for this phenotype.
Content may be subject to copyright.
Susceptibility to Cerebral Infarction in the Stroke-Prone
Spontaneously Hypertensive Rat Is Inherited as
a Dominant Trait
Julie A. Gratton, PhD; Andre Sauter, PhD; Markus Rudin, PhD; Kennedy R. Lees, MD, FRCP;
John McColl, MSc; John L. Reid, MD, FRCP; Anna F. Dominiczak, MD; I. Mhairi Macrae, PhD
Background and Purpose—Susceptibility to cerebral infarction was compared in stroke-prone spontaneously hypertensive
(SHRSP), normotensive Wistar-Kyoto (WKY) rats, and F1hybrids derived from a SHRSP/WKY cross.
Methods—The proximal left middle cerebral artery (MCA) was occluded under anesthesia and infarct volume assessed 24
hours later by magnetic resonance imaging and confirmed 5 days later by quantitative histopathology. Total hemispheric
infarct volume was expressed as a percentage of the total brain volume.
Results—Infarct volumes measured by MRI in adult SHRSP (19.562.0%) and F1hybrid rats (19.461.9%) were significantly
greater than in WKY (11.162.4; CI [6.07, 10.76]) and (5.93, 10.52), respectively, P,.001). Sensitivity to an ischemic
insult was unrelated to blood pressure: although systolic blood pressures differed between young versus adult male SHRSP
and between female versus male SHRSP and F1hybrids, infarct volumes were equal. A close correlation was found
between infarct volumes measured by MRI and histology (r5.92, P,.0001).
Conclusions—Outcome to MCA occlusion (MCAO) measured with MRI provides a reproducible and nonterminal
quantitative phenotypic marker of stroke susceptibility in the SHRSP. This is the first study to employ MCAO with MRI
to quantify stroke susceptibility in F1hybrid rats and indicates a dominant mode of inheritance for this phenotype. (Stroke.
1998;29:690-694.)
Key Words: cerebral infarction ngenetics nhypertension nmagnetic resonance imaging
Permanent MCAO is the definitive model of focal cerebral
ischemia.1,2 SHR and SHRSP have much larger and less
variable infarcts after MCA occlusion than all other rat
strains.3–5 Furthermore, this increased sensitivity to cerebral
ischemia, which we believe is genetically determined, may be
unrelated to hypertension because SHR and SHRSP suffer
large infarcts at 5 weeks of age before hypertension and
vascular hypertrophy are fully established.6,7 Studies by Coyle
and coworkers suggested that in the SHRSP susceptibility to
infarction was inherited as an autosomal recessive trait and that
decreased luminal diameters in vascular anastomoses between
the MCA and anterior cerebral artery were responsible for the
pathophysiology.8,9 The importance of vascular anastomoses
and genetic predisposition rather than blood pressure alone was
stressed further by evidence that rats made hypertensive by
deoxycorticosterone acetate and salt administration failed to
develop large infarcts after MCA occlusion,3whereas adult
SHR and SHRSP, in which hypertension had been treated
early, still developed large infarcts.10,11
The analysis of previous data therefore suggests that the
large infarcts induced by MCAO were due to inadequate
collateral blood flow and that this phenotype is genetically
See Editorial Comment, page 694
associated with but not directly linked to hypertension.12 This
implies that a gene marker or markers for infarct susceptibility
may exist both in animal models and perhaps also in humans.
Rubattu and coworkers13 recently performed a genome-wide
screening approach to an SHRSP/SHR cross using an alter-
native phenotype, latency to stroke after salt loading, as a
marker of stroke proneness. They identified three major loci
that contributed significantly to the variance of this stroke
phenotype in F2hybrids. Thus, in SHRSP, primary blood
pressure–independent genetic factors may play a critical role in
both stroke onset and increased susceptibility to infarction.
Previous studies in SHR and SHRSP used histological
methods to assess infarct size. These methods are very time-
consuming, difficult to perform in the large number of animals
required for genetic cosegregation analysis, and involve a
terminal end point. In the current study, MRI was used to
measure infarct volume after MCAO both in adult (24-week-
old) and young (9-week-old) SHRSP, in their normotensive
reference strain—the WKY rat, and in adult F1hybrids
obtained by crossing SHRSP and WKY rats. Quantitative
Received October 3, 1997; revision received December 5, 1997; accepted January 5, 1998.
From the Wellcome Surgical Institute (J.A.G., I.M.M.), the Department of Medicine and Therapeutics (K.R.L., J.L.R., A.F.D.), and the Department of
Statistics (J.M.) of the University of Glasgow (Scotland) and Novartis Pharma Ltd. (A.S., M.R.), Basel, Switzerland.
Correspondence to I. Mhairi Macrae, PhD, Wellcome Surgical Institute & Hugh Fraser Neuroscience Laboratories, University of Glasgow, Garscube
Estate, Glasgow G 61, 1QH, Scotland, UK.
E-mail m.macrae@udcf.gla.ac.uk
© 1998 American Heart Association, Inc.
690
by guest on October 23, 2017http://stroke.ahajournals.org/Downloaded from
histology at 5 days postischemia was carried out to confirm the
sensitivity and accuracy of the MRI measurements.
A preliminary report of these results has been published in
abstract form.14
Materials and Methods
Experimental Animals
Inbred colonies of SHRSP and WKY rats have been maintained in the
Department of Medicine and Therapeutics at the University of
Glasgow since 1991.15 The breeding animals were a gift from Dr D.F.
Bohr at the University of Michigan where they have been maintained
as inbred colonies for more than 15 years. F1hybrids were produced
by mating two SHRSP females with one WKY male. SHRSP, WKY,
and F1hybrids were weaned at 4 weeks, divided by sex, and
maintained in family groups (3 to 4 per cage) in constant temperature
at 21°C and 12-hour light/dark cycle (7 AM to 7 PM). SBP and heart
rate were measured in all animals by plethysmography as previously
described.16 To verify these physiological measurements, littermates of
SHRSP, WKY, and F1hybrids underwent direct blood pressure and
heart rate recordings using a telemetry system.16 MCAO was per-
formed on SHRSP and WKY at 9 weeks (SHRSP, n515; WKY,
n510) and 24 weeks (SHRSP, n510, WKY, n59) of age. F1hybrids
underwent MCAO at 24 weeks of age (n511). All experiments were
carried out in accordance with institutional and Home Office
guidelines.
Surgical Intervention to Produce
MCA Occlusion
Rats were anesthetized with isoflurane (1% to 2%) in oxygen–nitrous
oxide (1:2) via a face mask. The left MCA was permanently occluded
by electrocoagulation using the technique of Tamura et al1with minor
modifications.17 Anesthesia was given for no longer than 15 minutes.
MRI
A Biospec 47/15 spectrometer (Bruker) with imaging facility was
used. The radiofrequency probe was a home-built Alderman-Grant
type resonator18 with a 40-mm inner diameter and a length of 50 mm.
Twelve coronal sections, 1 mm thick, that covered the whole
forebrain were taken 24 hours after MCAO using a spin echo (SE)
sequence with an echo delay of 60 ms and a repetition delay of 2000
ms (SE 2000/60). The spatial resolution in the imaging plane (pixel
dimension) was 0.1630.16 mm2(field of view540 mm). Further
experimental details are described elsewhere.17,19 Infarct area in each
section was determined using a semiautomated segmentation proce-
dure based on intensity thresholding. Regional resolution into cortical
and striatal infarction involved interactive drawing of a borderline
between the respective structures prior to intensity thresholding. The
infarct size determined either by thresholding alone or by adding up
cortical and striatal values yielded identical numbers within error
limits. The total infarct volume was calculated by summation of the
number of pixels in each slice and multiplication by the pixel size and
slice thickness. Infarct volumes generated by MRI and histology were
expressed as a percentage of total brain volume to account for brain
swelling and differences in brain size between sexes and strains. Image
analysis was carried out by a person unaware of strain, age, or sex of
the animal.
Histology
Five days after MCAO, the rats were decapitated, and their brains
removed and immediately frozen on a block of dry ice. Coronal
cryostatic sections 20
m
m thick were cut at 12 equidistant levels (1 mm
apart, covering the entire forebrain), mounted on glass slides, and
stained with cresyl violet. The area of infarct in each section was
determined using a calibrated digitizing tablet from a video-image
analyzer. The sum of the infarct areas in the twelve sections, multiplied
by the slice thickness, was taken as total infarct volume. All infarct
volumes have been expressed as a percentage of the total
brain volume.
Statistical Analyses
The effects of systolic blood pressure, sex, strain, and age on infarct
volume established by MRI were examined using ANOVA and
ANCOVA. The Table displays the sample mean6SEM of SBP and
infarct volume for all groups of rats. Since no data were available from
young F1rats, two main analyses were required. In the first, the
(population) mean infarct volumes for adult and young SHRSP and
WKY rats were compared. In the second, (population) mean infarct
volumes of adult SHRSP, WKY, and F1rats were compared.
Both sets of analyses began by fitting a model containing all main
effects and interactions. Nonsignificant effects were then eliminated
beginning with the highest-order interaction or interactions. The final
model included all statistically significant interactions along with
lower-order terms in the same variables. Multiple comparisons were
investigated using Tukey’s method with an overall 95% confidence
level.
A paired ttest was used to compare infarct volumes obtained by
MRI with infarct volumes obtained by quantitative histology.
Results
Lack of Influence of BP on Infarct Volume in
Adult and Young Parental Strains
The relationship between infarct volume and blood pressure
can be judged from the Table. This shows that infarct volumes
are much smaller for the WKY rats (of both sexes and all ages)
than for the SHRSP and F1rats, which also generally have
higher blood pressures. There is, however, no evidence of a
correlation between infarct volume and blood pressure within
any group of rats: (adult SHRSP r5.360, P5.307; adult WKY
r52.245, P5.526; young SHRSP r5.262, P5.346; young
WKY r5.039, P5.921; F1hybrids r52.275, P5.414).
When the full ANCOVA model was fitted to the data for
young and adult SHRSP and WKY rats, no single term
involving blood pressure was statistically significant. Subse-
quent removal of these terms, beginning with the highest-
order interaction, did not result in lower-order terms involving
blood pressure becoming significant.
Consequently, a model was fitted that did not include the
main effect of blood pressure, or any interaction involving
blood pressure. This reduced model was tested within the full
model previously fitted, and was not rejected (F50.425, df58,
28, P5.90). It was concluded that blood pressure did not
influence infarct volume, on average, in any group of rats.
The reduced model was an ANOVA model in three
explanatory variables, namely strain, age (adult or young), and
sex. No individual term involving sex was statistically signifi-
cant and, after checking intermediate models, all of these terms
were removed. Again, this reduced model was tested within
the previous model and was not rejected (F50.627, df54, 36,
P5.63). It was concluded that there was no difference, on
average, between infarct volumes for male and female rats in
Selected Abbreviations and Acronyms
MCA 5middle cerebral artery
MCAO 5MCA occlusion
SBP 5systolic blood pressure
SHR 5spontaneously hypertensive rat
SHRSP 5stroke prone SHR substrain
WKY 5Wistar-Kyoto
Gratton et al 691
by guest on October 23, 2017http://stroke.ahajournals.org/Downloaded from
either age group of either strain. Consequently, data for both
sexes were combined for further comparisons of age groups
and strains.
Sensitivity to Ischemic Insult in Adult and
Young Parental Strains
In the reduced ANOVA model, which included only strain
and age group, the interaction term was not statistically
significant (P5.214), but the main effects of both strain and age
were statistically significant. Mean infarct volumes were sig-
nificantly greater in SHRSP than in WKY rats in the same age
group (95% confidence interval [7.96 to 10.96], P,.001).
Also, overall mean infarct volumes were significantly greater in
adult rats than in young rats (95% confidence interval [0.25 to
3.25], P5.023).
Lack of Influence of Blood Pressure on Infarct
Volume in Adult Parental and F1Hybrids
Again, when a full ANCOVA model was fitted to the data
from adult rats of all three strains, no term involving blood
pressure was statistically significant. Proceeding as before, a
reduced model that omitted all the terms involving blood
pressure was tested within the full model, and was not rejected
(F50.811, df56, 18, P5.58). We concluded that blood
pressure did not influence infarct volume, on average, in any
group of adult rats.
In the reduced ANOVA model, which included sex and
strain only, neither the interaction term nor the main effect of
gender was statistically significant. A reduced (one-way)
ANOVA model in strain alone was tested within the previous
model and was not rejected (F50.441, df55, 24, P5.82). We
concluded that there was no difference, on average, between
infarct volumes for male and female rats in any strain of adult
rat. Consequently, data for both sexes were combined for a
further analysis of the three strains.
Sensitivity to Ischemic Insult in Adult Parental
and F1Hybrids
There was a highly significant effect of strain on the average
infarct volume (P,.001). Simultaneous confidence intervals
for all pairwise comparisons showed that adult SHRSP had a
significantly greater mean infarct volume than adult WKY
rats(confidence interval 6.07 to 10.76). Adult F1rats, too, had
a significantly higher mean infarct volume than adult WKY
rats (confidence interval 5.93 to 10.52). There was no signif-
icant difference between the mean infarct volumes of adult
SHRSP and F1rats (confidence interval –2.03 to 2.42); indeed
the sample mean infarct volumes of these two groups were
virtually identical (see Table).
MRI Correlated With Histology
The use of MRI for mapping infarct volume was validated by
comparison with measurements made by quantitative histology
4 days after the animals were initially imaged by MRI. Fig 1
illustrates the strong association between the two measure-
ments in adult and young SHRSP and WKY rats, which
generated a sample correlation coefficient of r5.92 (P,.0001).
Although this indicates that the two measures were strongly
related, it should be noted that the MRI measurement was
greater than the histological measurement in almost every rat
because of acute edema of the infarcted area at 24 hours, which
would have resolved to a certain extent by 5 days postischemia.
A 95% confidence interval for the mean paired difference
between the MRI and histological measurements on the same
rat is 4.35 to 5.72, P,.0001.
Discussion
Infarct volume after MCA occlusion is a highly relevant
phenotype for demonstrating sensitivity to an ischemic insult.
MRI is a precise, nonterminal method for quantitation of
infarct volume. The current study is the first to demonstrate
that combination of this phenotype and technique provides a
very powerful means of investigating the genetics of stroke.
The present results confirm the bimodal distribution of the
MCAO phenotype in parental SHRSP and WKY strains (Fig
2), which has been reported previously.3–8 Two further im-
portant findings are presented. First, a number of results in this
study support the hypothesis that sensitivity to an ischemic
insult in the SHRSP is independent of blood pressure: (1) SBP
Mean Blood Pressure and Infarct Volumes in All Groups
SHRSP WKY F1
Adult Young Adult Young Adult
Male Female Male Female Male Female Male Female Male Female
SBP, mm Hg 22065.0 15963.0 14063.4 15963.0 13563.0 13063.3 12862.0 12163.2 16763.7 13068.1
Infarct volume, % of whole brain 20.561.1 18.960.7 18.560.6 19.360.7 10.561.4 11.660.9 9.461.2 7.961.4 19.360.7 19.561.2
Data are presented as mean6SEM for SBP measured before MCAO and infarct volume measured by MRI. See “Methods” for explanation of groups.
Figure 1. Scattergram illustrating the significant correlation
between infarct volume measured by MRI and histology.
692 Cerebral Infarction in the Stroke-Prone Spontaneously Hypertensive Rat
by guest on October 23, 2017http://stroke.ahajournals.org/Downloaded from
is significantly lower in young versus adult male SHRSP while
there is no difference in infarct volume; (2) in young animals,
before hypertension is established, there is no significant
difference in SBP in male SHRSP and WKY but infarct
volume is significantly greater in the SHRSP; and (3) in adult
SHRSP and F1hybrids, SBP is significantly higher in males
than females but there is no sex-related difference in infarct
volume.
The second and most interesting finding is that the distri-
bution of infarct volumes in F1rats was virtually identical to the
distribution in the SHRSP, strongly suggesting a dominant
mode of inheritance for this phenotype. The significance of
this finding has prompted a genome-wide screen in F2hybrids
(F13F1cross) to investigate genetic markers for stroke severi-
ty.20 Previous studies that examined the genetics of stroke in
the SHRSP include an earlier cosegregation study by Coyle et
al in which focal ischemia was used to characterize the
stroke-prone phenotype8and two studies13,21 in which an
alternative phenotype was used, latency to stroke on a high salt
diet. Coyle’s studies suggested a single recessive gene was
responsible for the pathogenesis of stroke in the SHRSP.
Possible reasons for the different conclusion from the current
study may include their use of outbred normal Wistar rats
instead of inbred WKY rats and the possibility that there was a
less severe, more distal occlusion in much younger animals (F1
hybrids 8 to 12 weeks old). When they used latency to stroke,
Nagaoka et al21 reported this phenotype to be characterized by
a polygenic inheritance and more recently, Rubattu et al13
performing a genome-wide screen on an F2cross
(SHRSP3SHR) identified three major quantitative trait loci
that together accounted for 28% of the overall phenotypic
variance. However, it should be stated that the genes respon-
sible for the latency to stroke with a high salt diet may be quite
independent of those that determine the size of infarct after
cerebral vessel occlusion (ischemic sensitivity genes).
A number of hypotheses have been put forward to explain
the increased ischemic sensitivity in the SHRSP. The most
commonly cited hypotheses propose that the SHRSP exhibit
arterial hypertrophy in cerebral arteries, resulting in decreased
functional compliance with limited dilatation to ischemia. This
may be particularly important in collateral vessels where a
reduction in anastomotic diameter would result in collateral
flow impairment during ischemia. In support of this, MCAO
in normotensive animals is associated with a marked increase in
nitric oxide release in the ischemic region.22 Since central
nervous system nitric oxide synthase activity is reduced in
SHRSP compared with WKY,23 defective nitric oxide release
may be a contributory factor in the impaired collateral perfu-
sion of the ischemic area in SHRSP. In addition, SHRSP may
also demonstrate an intensified inflammatory response to the
ischemic insult that could further compromise flow.24 Indirect
evidence for an impaired collateral supply comes from neuro-
protection studies in hypertensive strains in which drugs with
flow-enhancing properties (eg, L-type calcium channel block-
ers) are found to be more effective than NMDA glutamate
antagonists with proven efficacy in normotensive strains.25,26
The present findings are consistent with a dominant mode of
inheritance for ischemic sensitivity in the SHRSP. Recent
studies from our laboratory20 and from Rubattu and cowork-
Figure 2. A, Representative T2-weighted MRI images obtained
24 hours after MCA occlusion in adult SHRSP and WKY rats. B,
Comparison of infarct volumes (mean6SEM) measured by MRI
24 hours post-MCAO in adult and young SHRSP and WKY,
*P,.001.
Gratton et al 693
by guest on October 23, 2017http://stroke.ahajournals.org/Downloaded from
ers13 provide strong evidence for the existence of primary
blood pressure independent genetic factors which influence
both latency to stroke13 and sensitivity to an ischemic insult20 in
the SHRSP. Whether outcome to stroke has a genetic basis in
man needs to be examined further but such research should be
strongly encouraged in view of these results.
Acknowledgments
This work was funded by the Wellcome Trust (Grant No. 045924/95)
and the Cunningham Trust. Dr Dominiczak is a British Heart
Foundation Senior Research Fellow.
References
1. Tamura A, Graham DI, McCulloch J, Teasdale GM. Focal cerebral
ischaemia in the rat: 1. Description of technique and early neuropatho-
logical consequences following cerebral artery occlusion. J Cereb Blood Flow
Metab. 1981;1:53–60.
2. Ginsberg MD, Busto R. Rodent models of cerebral ischaemia. Stroke.
1993;20:1627–1642.
3. Coyle P. Outcomes to middle cerebral artery occlusion in hypertensive and
normotensive rats. Hypertension. 1984;6(suppl I):69 –74.
4. Coyle P. Different susceptibilities to cerebral infarction in spontaneously
hypertensive (SHR) and normotensive Sprague-Dawley rats. Stroke. 1986;
17:520 –525.
5. Duverger D, Mackenzie ET. The quantitation of cerebral infarction fol-
lowing focal ischaemia in the rat: Influence of strain, arterial pressure, blood
glucose concentration and age. J Cereb Blood Flow Metab. 1988;8:474– 485.
6. Coyle P, Jokelainen PT. Differential outcome to middle cerebral artery
occlusion in spontaneously hypertensive stroke-prone rats (SHRSP) and
Wistar-Kyoto (WKY) rats. Stroke. 1993;14:605–611.
7. Coyle P. Middle cerebral artery occlusion in the young rat. Stroke. 1982;
13:855– 859.
8. Coyle P, Odenheimer DJ, Sing CF. Cerebral infarction after middle
cerebral artery occlusion in progenies of spontaneously stroke-prone and
normal rats. Stroke. 1984;15:711–716.
9. Coyle P, Heistad DD. Blood flow through cerebral collateral vessels in
hypertensive and normotensive rats. Hypertension. 1986;8(suppl II):67–71.
10. Slivka A. Effect of antihypertensive therapy on focal stroke in sponta-
neously hypertensive rats. Stroke. 1991;22:884– 888.
11. Fujii K, Weno BL, Baumbach GL, Heistad DD. Effect of antihypertensive
treatment on focal cerebral infarction. Hypertension. 1992;19:713–716.
12. Jacewicz M. The hypertensive rat and predisposition to cerebral infarction.
Hypertension. 1992;19:47–48.
13. Rubattu S, Volpe M, Kreutz R, Ganten U, Ganten D, Lindpaintner K.
Chromosomal mapping of quantitative trait loci contributing to stroke in a
rat model of complex human disease. Nat Genet. 1996;13:429– 434.
14. Gratton J, Sauter A, Rudin M, Macrae I, Lees K, McColl J, Reid J,
Dominiczak A. Susceptibility to cerebral infarction in offspring from cross-
breeding stroke-prone SHR and WKY assessed with MRI. J Hypertens.
1996;13(suppl 1):S204.
15. Dominiczak AF, McLaren Y, Kusel JR, Ball DL, Goodfriend TL, Bohr
DL, Reid JL. Lateral diffusion and fatty acid composition in vascular
smooth muscle membrane from stroke prone spontaneously hypertensive
rats. Am J Hypertens. 1993;6:1003–1008.
16. Davidson AO, Schork N, Jacques B, Sutcliffe RG, Reid JL, Dominiczak
AF. Blood pressure in genetically hypertensive rats: influence of the Y
chromosome. Hypertension. 1995;26:452–459.
17. Sauter A, Rudin M. Calcium antagonists reduce the extent of infarction in
rat middle cerebral artery occlusion model as determined by quantitative
magnetic resonance imaging. Stroke. 1986;17:1228–1234.
18. Alderman DW, Grant DM. An efficient decoupler coil design which
reduces heating in conductive samples in superconducting spectrometers. J
Magn Res Med. 1979;36:447–450.
19. Rudin M, Sauter A. In vivo NMR in pharmaceutical research. Magn Res
Imaging. 1992;10:723–731.
20. Jeffs B, Clark JS, Anderson NH, Gratton J, Brosnan MJ, Gaugier D, Reid
JL, Macrae IM, Dominiczak AF. Sensitivity to cerebral ischaemic insult in
a rat model of stroke is determined by a single genetic locus. Nat Genet.
1997;16:364 –367.
21. Nagaoka A, Iwatsuka H, Suzuoki Z, Okamoto K. Genetic predisposition
to stroke in the spontaneously hypertensive rats. Am J Physiol. 1976;230:
1354 –1359.
22. Zhang ZG, Chopp M, Bailey F, Malinski T. Nitric oxide changes in the rat
brain after transient middle cerebral artery occlusion. J Neurol Sci. 1995;
128:22–27.
23. Cabrera CL, Bealer SL, Bohr DF. Central depressor action of nitric oxide
is deficient in genetic hypertension. Am J Hypertens. 1996;9:237–241.
24. Barone FC, Price WJ, White RF, Willette RN, Feuerstein GZ. Genetic
hypertension and increased susceptibility to cerebral ischaemia. Neurosci
Biobehav Rev. 1992;16:219–233.
25. McCulloch J. Neuroprotective drug development in stroke: blood pressure
and its impact. J Hypertens Suppl. 1996;14:S131–S138.
26. Sauter A, Rudin M. Strain-dependent drug effects in rat middle cerebral
artery occlusion model of stroke. J Pharmacol Exp Ther. 1995;274:
1008 –1013.
Editorial Comment
The most widely used experimental model of cerebral infarc-
tion results from MCA occlusion in the rat. The severity of this
infarct is quantified by its volume, and in the current decade
MRI has been established as a precise tool for monitoring this
volume. Using these techniques, the Glasgow investigators
observed much larger infarcts in the hypertensive SHRSP rats
than in the normotensive WKY, yet they firmly established
that infarct size was independent of blood pressure. They do
discuss alternative hypotheses that could explain a decrease in
collateral blood flow and thereby be responsible for the large
infarcts in SHRSP. Most attractive among these hypotheses are
arterial hypertrophy and a deficit in nitric oxide release.
1
Following cross-breeding between SHRSP and WKY rats,
they found that the infarct size in the F1 generation rat was as
large as that in the SHRSP parental strain. This clear evidence
for dominance of the genetic trait of the large infarct size adds
to the spectacular identification by these investigators of the
quantitative trait locus on chromosome 5 as responsible for
stroke size in SHRSP.
2
It is of special interest to see Glasgow University regaining
its leadership role in hypertension-related research.
David F. Bohr, MD, Guest Editor
Department of Physiology
University of Michigan Medical School
Ann Arbor, Michigan
References
1. Cabrera CL, Bealer SL, Bohr DF. Central depressor action of nitric oxide
is deficient in genetic hypertension. Am J Hypertens. 1996;9:237–241.
2. Jeffs B, Clark JS, Anderson NH, Gratton J, Brosnan MJ, Gaugier D, Reid
JL, Macrae IM, Dominiczak AF. Sensitivity to cerebral ischemic insult in
a rat model of stroke is determined by a single genetic locus. Nat Genet.
1997;16:364 –367.
694 Cerebral Infarction in the Stroke-Prone Spontaneously Hypertensive Rat
by guest on October 23, 2017http://stroke.ahajournals.org/Downloaded from
Anna F. Dominiczak and I. Mhairi Macrae
Julie A. Gratton, Andre Sauter, Markus Rudin, Kennedy R. Lees, John McColl, John L. Reid,
Is Inherited as a Dominant Trait
Susceptibility to Cerebral Infarction in the Stroke-Prone Spontaneously Hypertensive Rat
Print ISSN: 0039-2499. Online ISSN: 1524-4628
Copyright © 1998 American Heart Association, Inc. All rights reserved.
is published by the American Heart Association, 7272 Greenville Avenue, Dallas, TX 75231Stroke doi: 10.1161/01.STR.29.3.690
1998;29:690-694Stroke.
http://stroke.ahajournals.org/content/29/3/690
World Wide Web at:
The online version of this article, along with updated information and services, is located on the
http://stroke.ahajournals.org//subscriptions/ is online at: Stroke Information about subscribing to Subscriptions:
http://www.lww.com/reprints
Information about reprints can be found online at: Reprints:
document. Permissions and Rights Question and Answer process is available in the
Request Permissions in the middle column of the Web page under Services. Further information about this
Once the online version of the published article for which permission is being requested is located, click
can be obtained via RightsLink, a service of the Copyright Clearance Center, not the Editorial Office.Strokein Requests for permissions to reproduce figures, tables, or portions of articles originally publishedPermissions:
by guest on October 23, 2017http://stroke.ahajournals.org/Downloaded from
... However, the effects of hypertension and aging on NO production during cerebral ischemia are unclear. Compared to WRs with normal blood pressure, SHRs are used as a model of hypertension [5]. It is known that cerebral infarction is worse in SHRs Int. ...
... Sci. 2023, 24, 12749 2 of 18 than WRs, as shown in studies using middle cerebral artery occlusion [5], and the concentration of NO release, detected using electrochemical microsensors, is significantly lower in spontaneously hypertensive rats (SHR-SP) than that in Spraigue-Dawley (SD) rats [6]. ...
Article
Full-text available
Nitric oxide (NO) is involved in the pathogenesis of cerebral ischemic injury. Here, we investigated the effects of aging on NO production during cerebral ischemia-reperfusion (IR). Male Wister rats (WRs) were assigned to 12-month-old (older; n = 5) and 3-month-old (younger; n = 7) groups. Similarly, male spontaneous hypertensive rats (SHRs) were allocated to 12-month-old (older; n = 6) and 3-month-old (younger; n = 8) groups. After anesthesia, their NO production was monitored using in vivo microdialysis probes inserted into the left striatum and hippocampus. Forebrain cerebral IR injuries were produced via ligation of the bilateral common carotid arteries, followed by reperfusion. The change in the NO3− of the older rats in the SHR groups in the striatum was less compared to that of the younger rats before ischemia, during ischemia, and after reperfusion (p < 0.05). In the hippocampus, the change in the NO3− of the older rats in the SHR groups was lower compared to that of the younger rats after reperfusion (p < 0.05). There were no significant differences between the two WR groups. Our findings suggested that aging in SHRs affected NO production, especially in the striatum, before and during cerebral ischemia, and after reperfusion. Hypertension and aging may be important factors impacting NO production in brain IR injury.
... 13 It is well documented that SHRs exhibit more severe ischemic brain damage than normotensive rats. 14,15 Previous studies from our group and others showed that stimulation of NKCC1 activity is involved in ischemic cell damage through NKCC1-mediated Na þ and Cl À overload, cytotoxic edema as well as excitotoxicity. [16][17][18][19] Interestingly, we have recently found that WNK3 and SPAK kinases are stimulated in cortical neurons and oligodendrocytes in mice after ischemic stroke. ...
... Normotensive WKY rats were less sensitive to ischemic stroke and exhibited a smaller infarct size (<20% hemispheric volume) after 24-48 h following permanent MCA occlusion. 14,15 In our study, similar basal levels of pNKCC1 protein were detected in WKY and SHR brains. No ischemia-induced elevation of pNKCC1 was detected in ischemic WKY brains at 6-h post-ischemia. ...
Article
Full-text available
Stimulation of Na⁺/H⁺ exchanger isoform 1 (NHE1) in astrocytes causes ionic dysregulation under ischemic conditions. In this study, we created a Nhe1flox/flox (Nhe1f/f) mouse line with exon 5 of Nhe1 flanked with two loxP sites and selective ablation of Nhe1 in astrocytes was achieved by crossing Nhe1f/f mice with Gfap-CreERT2 Cre-recombinase mice. Gfap-CreERT2+/−;Nhe1f/f mice at postnatal day 60–90 were treated with either corn oil or tamoxifen (Tam, 75 mg/kg/day, i.p.) for 5 days. After 30 days post-injection, mice underwent transient middle cerebral artery occlusion (tMCAO) to induce ischemic stroke. Compared with the oil-vehicle group (control), Tam-treated Gfap-CreERT2+/−;Nhe1f/f (Nhe1 KO) mice developed significantly smaller ischemic infarction, less edema, and less neurological function deficits at 1–5 days after tMCAO. Immunocytochemical analysis revealed less astrocytic proliferation, less cellular hypertrophy, and less peri-lesion gliosis in Nhe1 KO mouse brains. Selective deletion of Nhe1 in astrocytes also reduced cerebral microvessel damage and blood–brain barrier (BBB) injury in ischemic brains. The BBB microvessels of the control brains show swollen endothelial cells, opened tight junctions, increased expression of proinflammatory protease MMP-9, and significant loss of tight junction protein occludin. In contrast, the Nhe1 KO mice exhibited reduced BBB breakdown and normal tight junction structure, with increased expression of occludin and reduced MMP-9. Most importantly, deletion of astrocytic Nhe1 gene significantly increased regional cerebral blood flow in the ischemic hemisphere at 24 hr post-MCAO. Taken together, our study provides the first line of evidence for a causative role of astrocytic NHE1 protein in reactive astrogliosis and ischemic neurovascular damage.
... The SHR-SP model was derived from the spontaneously hypertensive (SHR) rat by inbreeding (Okamoto and Aoki, 1963). Phenotypes have been found to be autosomal dominant (Gratton et al., 1998) and can be identified by phenotyping rather than genotyping. ...
Article
Full-text available
Cerebral amyloid angiopathy (CAA), a common comorbidity of Alzheimer’s disease (AD), is a cerebral small vessel disease (CSVD) characterized by deposition of fibrillar amyloid β (Aβ) in blood vessels of the brain and promotes neuroinflammation and vascular cognitive impairment and dementia (VCID). Hypertension, a prominent non-amyloidal CSVD, has been found to increase risk of dementia, but clinical data regarding its effects in CAA patients is controversial. To understand the effects of hypertension on CAA, we bred rTg-DI transgenic rats, a model of CAA, with spontaneously hypertensive, stroke prone (SHR-SP) rats producing bigenic rTg-DI/SHR-SP and non-transgenic SHR-SP littermates. At 7 months (M) of age, cohorts of both rTg-DI/SHR-SP and SHR-SP littermates exhibit elevated systolic blood pressures. However, transgene human amyloid β-protein (Aβ) precursor and Aβ peptide levels, as well as behavioral testing showed no changes between bigenic rTg-DI/SHR-SP and rTg-DI rats. Subsequent cohorts of rats were aged further to 10 M where bigenic rTg-DI/SHR-SP and SHR-SP littermates exhibit elevated systolic and diastolic blood pressures. Vascular amyloid load in hippocampus and thalamus was significantly decreased, whereas pial surface vessel amyloid increased, in bigenic rTg-DI/SHR-SP rats compared to rTg-DI rats suggesting a redistribution of vascular amyloid in bigenic animals. There was activation of both astrocytes and microglia in rTg-DI rats and bigenic rTg-DI/SHR-SP rats not observed in SHR-SP rats indicating that glial activation was likely in response to the presence of vascular amyloid. Thalamic microbleeds were present in both rTg-DI rats and bigenic rTg-DI/SHR-SP rats. Although the number of thalamic small vessel occlusions were not different between rTg-DI and bigenic rTg-DI/SHR-SP rats, a significant difference in occlusion size and distribution in the thalamus was found. Proteomic analysis of cortical tissue indicated that bigenic rTg-DI/SHR-SP rats largely adopt features of the rTg-DI rats with enhancement of certain changes. Our findings indicate that at 10 M of age non-pharmacological hypertension in rTg-DI rats causes a redistribution of vascular amyloid and significantly alters the size and distribution of thalamic occluded vessels. In addition, our findings indicate that bigenic rTg-DI/SHR-SP rats provide a non-pharmacological model to further study hypertension and CAA as co-morbidities for CSVD and VCID.
... The SHRSP sub-strain of the SHR, created in 1974, is considered a robust model of hypertension and stroke. Although the precise loci are debated, SHRSP genetic susceptibility for hypertension and cerebral lesions is autosomal dominantly inherited (Gratton et al., 1998), allowing us to cross with the TgF344-AD (FAD) rat, producing a novel rat, expressing autosomal dominant familial AD genes, on the SHRSP background (SHRSP/FAD). ...
Article
Full-text available
Alzheimer’s disease (AD) and mixed dementia (MxD) comprise the majority of dementia cases in the growing global aging population. MxD describes the coexistence of AD pathology with vascular pathology, including cerebral small vessel disease (SVD). Cardiovascular disease increases risk for AD and MxD, but mechanistic synergisms between the coexisting pathologies affecting dementia risk, progression and the ultimate clinical manifestations remain elusive. To explore the additive or synergistic interactions between AD and chronic hypertension, we developed a rat model of MxD, produced by breeding APPswe/PS1ΔE9 transgenes into the stroke-prone spontaneously hypertensive rat (SHRSP) background, resulting in the SHRSP/FAD model and three control groups (FAD, SHRSP and non-hypertensive WKY rats, n = 8–11, both sexes, 16–18 months of age). After behavioral testing, rats were euthanized, and tissue assessed for vascular, neuroinflammatory and AD pathology. Hypertension was preserved in the SHRSP/FAD cross. Results showed that SHRSP increased FAD-dependent neuroinflammation (microglia and astrocytes) and tau pathology, but plaque pathology changes were subtle, including fewer plaques with compact cores and slightly reduced plaque burden. Evidence for vascular pathology included a change in the distribution of astrocytic end-foot protein aquaporin-4, normally distributed in microvessels, but in SHRSP/FAD rats largely dissociated from vessels, appearing disorganized or redistributed into neuropil. Other evidence of SVD-like pathology included increased collagen IV staining in cerebral vessels and PECAM1 levels. We identified a plasma biomarker in SHRSP/FAD rats that was the only group to show increased Aqp-4 in plasma exosomes. Evidence of neuron damage in SHRSP/FAD rats included increased caspase-cleaved actin, loss of myelin and reduced calbindin staining in neurons. Further, there were mitochondrial deficits specific to SHRSP/FAD, notably the loss of complex II, accompanying FAD-dependent loss of mitochondrial complex I. Cognitive deficits exhibited by FAD rats were not exacerbated by the introduction of the SHRSP phenotype, nor was the hyperactivity phenotype associated with SHRSP altered by the FAD transgene. This novel rat model of MxD, encompassing an amyloidogenic transgene with a hypertensive phenotype, exhibits several features associated with human vascular or “mixed” dementia and may be a useful tool in delineating the pathophysiology of MxD and development of therapeutics.
... In the setting of IS, hypertension also plays a role in microglial polarization and the establishment of a proinflammatory state associated with increased infarct volume and worsened functional outcome [97,98]. SHRSP display a significant increase of activated microglia compared to WKY not only in the infarct core and the peri-infarct area but interestingly also in the contralateral hemisphere [98]. ...
Article
Full-text available
Hypertension is the first modifiable vascular risk factor accounting for 10.4 million deaths worldwide; it is strongly and independently associated with the risk of stroke and is related to worse prognosis. In addition, hypertension seems to be a key player in the implementation of vascular cognitive impairment. Long-term hypertension, complicated or not by the occurrence of ischemic stroke, is often reviewed on its vascular side, and parenchymal consequences are put aside. Here, we sought to review the impact of isolated hypertension or hypertension associated to stroke on brain atrophy, neuron connectivity and neurogenesis, and phenotype modification of microglia and astrocytes. Finally, we discuss the impact of antihypertensive therapies on cell responses to hypertension and functional recovery. This attractive topic remains a focus of continued investigation and stresses the relevance of including this vascular risk factor in preclinical investigations of stroke outcome.
... This is an inbred rat strain known to be a relevant rodent model of human sporadic SVD (19,20). These DM rats are hypertensive from 6 weeks, show classical SVD pathology from 8 weeks, and suffer strokes from 20 weeks of age (20)(21)(22)(23)(24). As controls, we used the parent strain of the DM rat, Wistar Kyoto (WKY) rats, from a colony maintained in parallel. ...
Article
Dementia is a major social and economic problem for our aging population. One of the most common of dementia in the elderly is cerebral small vessel disease (SVD). Magnetic resonance scans of SVD patients typically show white matter abnormalities, but we do not understand the mechanistic pathological link between blood vessels and white matter myelin damage. Hypertension is suggested as the cause of sporadic SVD, but a recent alternative hypothesis invokes dysfunction of the blood-brain barrier as the primary cause. In a rat model of SVD, we show that endothelial cell (EC) dysfunction is the first change in development of the disease. Dysfunctional ECs secrete heat shock protein 90α, which blocks oligodendroglial differentiation, contributing to impaired myelination. Treatment with EC-stabilizing drugs reversed these EC and oligodendroglial pathologies in the rat model. EC and oligodendroglial dysfunction were also observed in humans with early, asymptomatic SVD pathology. We identified a loss-of-function mutation in ATPase11B, which caused the EC dysfunction in the rat SVD model, and a single-nucleotide polymorphism in ATPase11B that was associated with white matter abnormalities in humans with SVD. We show that EC dysfunction is a cause of SVD white matter vulnerability and provide a therapeutic strategy to treat and reverse SVD in the rat model, which may also be of relevance to human SVD.
... To test this hypothesis, we assessed not only brain tracer retention at the standard 2-3hrs post-administration time, but also FMISO kinetic rate constants, specifically the irreversible trapping constant thought to reflect tissue hypoxia, by dynamically acquiring FMISO brain data since administration time and applying our previously reported quantitative kinetic model [32]. In addition, to assess the effects of hyperoxia on FMISO uptake in distinct tissue situations, we used both Wistar rats and their spontaneously hypertensive counterparts (SHRs), whose tissue vulnerability to focal cerebral ischemia, namely rate of demise of the severely hypoxic but viable tissue (i.e., the penumbra) [33-35] and final infarct volume [33, [36][37][38][39][40], widely differ as a result of underlying differences in functionality and structure of the pial vascular tree [39,[41][42][43][44][45], in turn mimicking clinical heterogeneity. In parallel to testing the effects of hyperoxia on FMISO uptake, and to inform the findings thereof, we also assessed its effects on tissue oxygen tension in both ischemic and non-ischemic cortex in a different group of animals. ...
Article
Full-text available
Purpose: Mapping brain hypoxia is a major goal for stroke diagnosis, pathophysiology and treatment monitoring. 18F-fluoro-misonidazole (FMISO) positron emission tomography (PET) is the gold standard hypoxia imaging method. Normobaric hyperoxia (NBO) is a promising therapy in acute stroke. In this pilot study, we tested the straightforward hypothesis that NBO would markedly reduce FMISO uptake in ischemic brain in Wistar and spontaneously hypertensive rats (SHRs), two rat strains with distinct vulnerability to brain ischemia, mimicking clinical heterogeneity. Methods: Thirteen adult male rats were randomized to distal middle cerebral artery occlusion under either 30% O2 or 100% O2. FMISO was administered intravenously and PET data acquired dynamically for 3hrs, after which magnetic resonance imaging (MRI) and tetrazolium chloride (TTC) staining were carried out to map the ischemic lesion. Both FMISO tissue uptake at 2-3hrs and FMISO kinetic rate constants, determined based on previously published kinetic modelling, were obtained for the hypoxic area. In a separate group (n = 9), tissue oxygen partial pressure (PtO2) was measured in the ischemic tissue during both control and NBO conditions. Results: As expected, the FMISO PET, MRI and TTC lesion volumes were much larger in SHRs than Wistar rats in both the control and NBO conditions. NBO did not appear to substantially reduce FMISO lesion size, nor affect the FMISO kinetic rate constants in either strain. Likewise, MRI and TTC lesion volumes were unaffected. The parallel study showed the expected increases in ischemic cortex PtO2 under NBO, although these were small in some SHRs with very low baseline PtO2. Conclusions: Despite small samples, the apparent lack of marked effects of NBO on FMISO uptake suggests that in permanent ischemia the cellular mechanisms underlying FMISO trapping in hypoxic cells may be disjointed from PtO2. Better understanding of FMISO trapping processes will be important for future applications of FMISO imaging.
... This was expected on the basis of strain comparison data from individual studies. [96][97][98] In contrast, Lewis rats had comparatively small strokes (17% of the hemisphere), whilst Fischer 344 rats (23%), Long Evans (26%), Sprague-Dawley category. The infarct size represents an average infarct volume, expressed as a percentage of the hemisphere, for each category. ...
Chapter
Full-text available
A quantitative and qualitative comparison of contemporary neuroprotection and thrombolytic stroke trials and their preclinical animal counterparts has been undertaken, with metaanalysis [DerSimonian, R., Laird, N., 1986. Metaanalysis in clinical trials. Control. Clin. Trials 7 (3), 177-188.] used to evaluate imaging and histological outcomes.Results from 35 clinical trials including 5,532 patients were compared with data from 3,145 preclinical acute-stroke experiments in 45,476 animals. While clinical trials tended to be of higher methodological quality and have larger sample sizes than animal experiments (71 patients vs. 7 animals per group), both were similarly underpowered owing to the greater variability in human stroke (average standard deviation of mean in humans 99% vs. 30% in animals). Proportionally, animal infarcts were almost 4 times larger than human infarcts in untreated control groups (27% vs. 8% of the hemisphere) although there was considerable variability in size owing to comorbidities and stroke type. Eighty-six percent of animal studies and 54% of clinical trials reported smaller infarcts in groups receiving treatment, with 41% of clinical trials reporting an improvement in the prespecified hypothesis. Animal experiments were not effective in predicting individual trial results, nor the level of neuroprotection, however, there was a fair agreement between the direction of the animal and clinical outcomes when looking at the overall direction of drug outcome. As a drug-screening tool, experimental stroke studies need refinement. Rational frameworks for translational research will help.
Article
Although chronic arterial hypertension (CAH) represents the major comorbid factor in stroke, it is rarely integrated in preclinical studies of stroke. The majority of those investigations employ spontaneously hypertensive rats (SHR) which display a susceptibility to ischemic damage independent of hypertension. Here, we used a renovascular model of hypertension (RH) to examine, with magnetic resonance imaging (MRI), brain alterations during the development of hypertension and after brain ischemia. We also examined whether MRI-derived parameters predict the extent of ischemia-induced brain damage. RH was induced according to the two-kidney one-clip model and multiparametric MRI was performed at 3, 6, 9, and 12 weeks after hypertension and also at 10, 50, and 60 min following stroke. Blood pressure values increased progressively and reached a plateau at 6 weeks after RH induction. At 12 weeks, all hypertensive animals displayed spontaneous brain lesions (hemorrhages, deep and cortical lesions, ventricular dilatation), increased apparent diffusion coefficient (ADC) values in the corpus callosum and higher fractional anisotropy in the cortex. Following ischemia, these animals showed larger brain lesions (406 ± 82 vs. 179 ± 36 mm³, p < 0.002) which correlated with ADC values at chronic stage of hypertension. This model of hypertension displays many characteristics of the neuropathology of human CAH. The use of this model in stroke studies is relevant and desirable.
Chapter
Translation of the explosion in knowledge of acute ischemic stroke into satisfactory treatment regimens has yet to happen. At present tPA, intra-arterial prourokinase and low-molecular-weight heparin form the vanguard for therapeutic intervention, yet these treatments have a limited therapeutic window. Part of this expansion in understanding has been driven by the contribution of stroke genetics and genomics. However, despite the enormous preclinical and clinical information of receptors, enzymes, second messenger systems, and so forth, that are implicated in stroke pathophysiology, delivery of novel drug treatment has been slow. This introductory chapter discusses the multiple sources of clinical and preclinical genetic information. It will describe the importance of integrating expression information into multiple preclinical models with temporal and spatial roles in lesion pathology and, furthermore developing an understanding of function in the clinic before claiming a role in ischemic stroke. The goal of such a holistic integration of information is to increase the yield from current datasets of gene expression and ultimately to help expand the choice of treatment available to the physician and patient.
Article
Full-text available
Ischaemic stroke is a complex disorder caused by a combination of genetic and environmental factors. Clinical and epidemiological studies have provided strong evidence for genetic influences in the development of human stroke and several mendelian traits featuring stroke have been described. The genetic analysis of the non-mendelian, common ischaemic stroke in humans is hindered by the late onset of the disease and the mode of inheritance, which is complex, polygenic and multifactorial. An important approach to the study of such polygenic diseases is the use of appropriate animal models in which individual contributing factors can be recognized and analysed. The spontaneously hypertensive stroke-prone rat (SHRSP) is an experimental model of stroke characterized by a high frequency of spontaneous strokes as well as an increased sensitivity to experimentally induced focal cerebral ischaemia. Rubattu et al. performed a genomewide screen in an F2 cross obtained by mating SHRSP and SHR, in which latency to stroke on Japanese rat diet was used as a phenotype. This study identified three major quantitative trait loci (QTLs), STR-1-3. Of these, STR-2 and 3 conferred a protective effect against stroke in the presence of SHRSP alleles and STR-2 co-localized with the genes encoding for atrial natriuretic and brain natriuretic factors. Our investigation was designed to identify the genetic component responsible for large infarct volumes in the SHRSP in response to a focal ischaemic insult by performance of a genome scan in an F2 cross derived from the SHRSP and the normotensive reference strain, WKY rat. We identified a highly significant QTL on rat chromosome 5 with a lod score of 16.6 which accounts for 67% of the total variance, co-localizes with the genes encoding atrial and brain natriuretic factor and is blood pressure independent.
Article
Hypertension and stroke in spontaneously hypertensive rats (SHR) were investigated genetically using stroke-prone SHR (A3), stroke-resistant SHR (C) and their hybrids, hybrid of A3 and C (F1), offspring of F1 X F1 (F2), and those of backcrossing of F1 to the respective parental strains, BC(F1 X A3) and BC(F1 X C). The average blood pressure measured without anesthesia increased in the following order during the experimental period: C less than BC (F1 X C) less than F1 approximately F2 less than BC(F1 X A3) less than A3. The F2 represented a wider spread of variation than the F1, with some of the pressure extending into the range of both parental strains. When the drinking water was replaced with a 1% salt solution, the blood pressure increased and the onset of stroke markedly accelerated in all groups of SHR. Under the hypertensive conditions, the incidence of stroke was associated with A3-gene concentration rather than with the level of blood pressure. Similar but less dramatic effects of salt were observed in another series of hybrid groups derived from A3 and normal Wistar-Kyoto rats. These findings suggest that the genetic factors are of great importance in the development of stroke as well as hypertension in the SHR.
Article
In vivo NMR techniques are currently well established in pharmaceutical research and will likely become increasingly important in the future, as they procure noninvasively morphological, physiological, and biochemical information. The status of magnetic resonance imaging (MRI) and spectroscopy (MRS) in drug development is discussed on the basis of the characterization and evaluation of a rat model of ischemic stroke and the development and profiling of drugs for cerebral ischemia in this model. It can be concluded that MRI is well suited for drug screening (quantitative determination of lesion size), while dynamic MRI and MRS techniques provide relevant information on the mechanism of drug actions. The possibility to follow changes, pathological and therapeutic, in the same individual is important from two points of view. First, variations due to interindividual differences may be eliminated, increasing the statistical power of the results. Second, dose and/or time dependence of a drug can be explored in the same individual. As a result, the number of animals required for a study will be reduced, which from both ethical and economic aspects is highly desirable.
Article
The goal of the current study was to determine whether treatment of hypertension reduces cerebral infarction after occlusion of the middle cerebral artery in stroke-prone spontaneously hypertensive rats (SHRSPs). Three-month-old SHRSPs received untreated drinking water or drinking water containing cilazapril, an angiotensin converting enzyme inhibitor, or hydralazine and hydrochlorothiazide. After 3 months of treatment, the left middle cerebral artery was occluded and neurological deficit was evaluated. Infarct volume was measured 3 days after occlusion using computer imaging techniques from brain slices. Cilazapril and hydralazine with hydrochlorothiazide were equally effective in reducing systolic blood pressure in SHRSPs. One day after occlusion of the middle cerebral artery, neurological deficit was decreased by both cilazapril and hydralazine with hydrochlorothiazide compared with untreated SHRSPs, and the deficit 3 days after occlusion was decreased significantly only by cilazapril. Infarct volume was 178 +/- 7 mm3 (mean +/- SEM) in untreated SHRSPs, and it was significantly reduced to 117 +/- 15 mm3 by hydralazine with hydrochlorothiazide and to 101 +/- 17 mm3 by cilazapril. Infarct volume in Wistar-Kyoto rats was 27 +/- 16 mm3. Thus, reduction in arterial pressure by hydralazine with hydrochlorothiazide or an angiotensin converting enzyme inhibitor is protective against focal cerebral ischemia in SHRSPs.
Article
A review of the sensitivity of genetically hypertensive rats to cerebral ischemia was presented together with original data describing the systematic comparison of the effects of focal ischemia (permanent and temporary with reperfusion) performed in hypertensive and normotensive rats (i.e., blood pressures verified in conscious instrumented rats). Microsurgical techniques were used to isolate and occlude the middle cerebral artery (MCAO) of spontaneously hypertensive (SHR), Sprague-Dawley (SD) and Wistar Kyoto (WKY) rats at the level of the inferior cerebral vein. Following permanent (24 h) MCAO, persistent and similar decreases in local microvascular perfusion (i.e., to 15.6 +/- 1.7% of pre-MCAO levels) were verified in the primary ischemic zone of the cortex for all strains using Laser-Doppler flowmetry. A contralateral hemiplegia that occurred following MCAO, evidenced by forelimb flexion and muscle weakness, was greater in SHR (neurological grade = 2.0 +/- 0.1) than SD (1.0 +/- 0.4) or WKY (0.7 +/- 0.4) rats (N = 7-9, p less than 0.05). SHR also exhibited sensory motor deficits following MCAO compared to sham-operation, with decreased normal placement response of the hindlimb (% normal = 20 vs. 83, N = 23-30, p decreased rota-rod (41 +/- 7 vs. 126 +/- 19 on rod, N = 10-15, p less than 0.05) and balance beam (25 +/- 5 vs. 116 +/- 29 s on beam, N = 5-7, p less than 0.05) performance. However, an index of general motor activity was not affected by permanent MCAO. Triphenyltetrazolium-stained forebrain tissue analyzed by planimetry revealed a significantly larger and more consistent cortical infarction in SHR (hemispheric infarction = 27.9 +/- 1.5%) compared to SD (15.4 +/- 4.1%) and WKY (4.0 +/- 2.4%) rats (N = 7-9, p less than 0.05), occupying predominantly the frontal and parietal areas. Also, a significant degree of ipsilateral hemispheric swelling (4.6 +/- 0.9%, N = 7-9, p less than 0.05) and increased brain water content (78.4 +/- 0.3% to 80.4 +/- 0.2%, N = 8-9, p less than 0.05) was identified in SHR that was not observed in SD or WKY rats. A novel model of temporary MCAO also was evaluated in the hypertensive and normotensive rat strains. Initially, the effect of increasing MCAO-time followed by 24 h reperfusion in SHR was studied. During temporary MCAO (20 to 300 min), persistent and stable decreases in local microvascular perfusion (i.e., to 15-20% of pre-MCAO levels) were verified in the primary ischemic zones of the cortex.(ABSTRACT TRUNCATED AT 400 WORDS)
Article
Spontaneously hypertensive rats subjected to focal cerebral ischemia develop larger infarcts than normotensive rat strains. To determine whether antihypertensive therapy decreases infarct volume in hypertensive rats, 60 13-week-old animals were treated with 20 mg/kg hydralazine added daily to the drinking water for 1.5, 6, 10, or 16 weeks and then subjected to focal cerebral ischemia by tandem right common carotid artery and middle cerebral artery occlusion. Blood pressure in the treated groups was substantially lower than that in untreated groups after 1 week of hydralazine therapy and remained lower for the entire treatment period in all four experiments. Mean infarct volume in spontaneously hypertensive rats treated for 10 (p = 0.02) or 16 (p = 0.005) weeks, but not 1.5 or 6 weeks, was significantly less than that in the untreated controls. The percentage reduction of infarct volume in animals treated for 10 and 16 weeks was similar. This study demonstrates that antihypertensive therapy decreases infarct volume in hypertensive rats subjected to focal cerebral ischemia. This treatment effect appears to be dependent on the duration of therapy, and the magnitude of the treatment effect seems to plateau by 10 weeks of therapy.
Article
The use of physiologically regulated, reproducible animal models is crucial to the study of ischemic brain injury--both the mechanisms governing its occurrence and potential therapeutic strategies. Several laboratory rodent species (notably rats and gerbils), which are readily available at relatively low cost, are highly suitable for the investigation of cerebral ischemia and have been widely employed for this purpose. We critically examine and summarize several rodent models of transient global ischemia, resulting in selective neuronal injury within vulnerable brain regions, and focal ischemia, typically giving rise to localized brain infarction. We explore the utility of individual models and emphasize the necessity for meticulous experimental control of those variables that modulate the severity of ischemic brain injury.